Shenzhen Hepalink Pharmaceutical Group Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Yu Shan
Chief executive officer
CN¥2.6m
Total compensation
| CEO salary percentage | 49.5% |
| CEO tenure | 26.6yrs |
| CEO ownership | n/a |
| Management average tenure | 2.4yrs |
| Board average tenure | 13.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CN¥146m |
| Jun 30 2024 | n/a | n/a | -CN¥243m |
| Mar 31 2024 | n/a | n/a | -CN¥695m |
| Dec 31 2023 | CN¥3m | CN¥1m | -CN¥783m |
| Sep 30 2023 | n/a | n/a | CN¥218m |
| Jun 30 2023 | n/a | n/a | CN¥340m |
| Mar 31 2023 | n/a | n/a | CN¥559m |
| Jan 01 2023 | n/a | n/a | CN¥727m |
| Sep 30 2022 | n/a | n/a | CN¥432m |
| Jun 30 2022 | n/a | n/a | CN¥414m |
| Mar 31 2022 | n/a | n/a | CN¥332m |
| Jan 01 2022 | n/a | n/a | CN¥241m |
| Sep 30 2021 | n/a | n/a | CN¥777m |
| Jun 30 2021 | n/a | n/a | CN¥781m |
| Mar 31 2021 | n/a | n/a | CN¥912m |
| Dec 31 2020 | CN¥5m | CN¥2m | CN¥1b |
| Sep 30 2020 | n/a | n/a | CN¥1b |
| Jun 30 2020 | n/a | n/a | CN¥1b |
| Mar 31 2020 | n/a | n/a | CN¥808m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥1b |
Compensation vs Market: Yu's total compensation ($USD365.42K) is about average for companies of similar size in the Hong Kong market ($USD487.65K).
Compensation vs Earnings: Yu's compensation has increased whilst the company is unprofitable.
CEO
Yu Shan (64 yo)
26.6yrs
Tenure
CN¥2,647,000
Compensation
Mr. Yu Shan co-founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in April 1998 and has been its General Manager since April 21, 1998 and serves as its Group Vice President. From August 1982 to Febru...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 26.6yrs | CN¥2.98m | no data | |
| Co-Founder | 26.6yrs | CN¥2.65m | no data | |
| VP of Finance | 1.3yrs | CN¥992.60k | no data | |
| VP, Deputy GM & Director | no data | CN¥2.45m | no data | |
| Company Secretary | 3.1yrs | CN¥1.67m | no data | |
| Chief Business Officer | no data | no data | no data | |
| Senior Vice President of Global Supply Chain | 1.7yrs | no data | no data |
2.4yrs
Average Tenure
60yo
Average Age
Experienced Management: 9989's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 26.6yrs | CN¥2.98m | no data | |
| Co-Founder | 26.6yrs | CN¥2.65m | no data | |
| VP, Deputy GM & Director | 26.6yrs | CN¥2.45m | no data | |
| Supervisor | 16.9yrs | no data | no data | |
| Employee Supervisor | 16.9yrs | no data | no data | |
| Chairman of Supervisory Board | 10.5yrs | no data | no data | |
| Independent Non-Executive Director | 4.9yrs | CN¥100.00k | no data | |
| Chairman of Hepalink’s Scientific Advisory Board | no data | no data | no data | |
| Member of Hepalink’s Scientific Advisory Board | no data | no data | no data | |
| Director | 1.5yrs | CN¥3.49m | no data | |
| Independent Non-Executive Director | 1.5yrs | CN¥58.00k | no data | |
| Independent Non-Executive Director | 1.5yrs | CN¥58.00k | no data |
13.7yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 9989's board of directors are seasoned and experienced ( 13.7 years average tenure).